Table 16.
Propolis Origin | Parasitic Species | Identified Compounds | Activity | Ref. |
---|---|---|---|---|
Egypt | F. gigantica | Diprenyl-dihydrocoumaric acids, coumarate esters, ferulate esters, hydroxy acetophenones, furanon derivative, furofuran lignans, benzofuran lignans, and valeric acids derivatives | Alteration in the architecture, inhibitory activity on the viability and hatchability of immature helminths (10–800 μg/mL) | [170,171] |
S. mansoni-infected mice | N.I. | Propolis administration (500 mg/kg) not eliminated the worms of infected mice, but significantly reduced the hepatic granuloma number, hepatic, splenic and plasma MPO activity, as well the liver and thymus NO levels; also, regulation of plasma antioxidant proteins evidenced by decrease in MDA and normalization of GSH | [172] | |
Turkey | E. granulosus | N.I. | Propolis (1 µg/mL) killed all the protoscoleces | [173] |
Brazil (essential oil of red propolis) | T. cati | N.I. | Have 100% larvicidal effect after treatment (1 µg/mL) of 48 h and can suppress the ability of the treated T. cati larvae to infect the mice | [174] |
Libya (five different samples) | T. spiralis | Cycloartanol, mangiferolic acid, agathadiol, isocupressic acid, isoagatholal | All propolis samples (4.7–59.3 μg/mL) showed moderate activity | [175] |
N.I., none identified; MPO, myeloperoxidase; MDA, malondialdehyde; GSH, glutathione.